Neumora Therapeutics, Inc. NMRA Q4 2025 Annual earnings
Reported March 16, 2026 · Before market open
EPS-$0.35Miss by $0.01
EPS estimate-$0.34
Next report
Aug 5, 2026 (In 1 week)EPS estimate-$0.23
Versus estimates
Diluted EPS
Ask the moment Neumora Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Neumora Therapeutics, Inc. report Q4 2025 earnings?
- Neumora Therapeutics, Inc. (NMRA) reported Q4 2025 earnings on March 16, 2026 before market open.
- What were Neumora Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- Neumora Therapeutics, Inc. reported eps of $-0.35 for Q4 2025.
- Did Neumora Therapeutics, Inc. beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.34 by $0.01.
- How did Neumora Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 5.4% from $-0.37.
- Where can I find Neumora Therapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001193125-26-130388) directly on SEC EDGAR. The filing index links above go to sec.gov.